GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
MLAAX
Price
$8.34
Change
-$0.35 (-4.03%)
Updated
Apr 10 closing price
Net Assets
12.04B
Ad is loading...

GFACX vs MLAAX

Header iconGFACX vs MLAAX Comparison
Open Charts GFACX vs MLAAXBanner chart's image
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
NYLI Winslow Large Cap Growth
Price$8.34
Change-$0.35 (-4.03%)
VolumeN/A
Net Assets12.04B
GFACX vs MLAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MLAAX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MLAAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. MLAAX (12B). GFACX (0.00) and MLAAX (0.00) have matching dividends . GFACX was incepted earlier than MLAAX: GFACX (24 years) vs MLAAX (30 years). GFACX (1.36) is less costly to investors than MLAAX (0.95). MLAAX is a more actively managed with annual turnover of: 70.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than MLAAX: GFACX (250) vs MLAAX (15000). GFACX annual gain was more profitable for investors over the last year : -3.95 vs. MLAAX (-17.34). GFACX return over 5 years is better than : 40.74 vs. MLAAX (-1.30).
GFACXMLAAXGFACX / MLAAX
Total Expense Ratio1.360.94145%
Annual Report Gross Expense Ratio1.360.95143%
Fund Existence24 years30 years-
Gain YTD-7.732-12.67061%
Front LoadN/A6%-
Min. Initial Investment250150002%
Min. Initial Investment IRAN/AN/A-
Net Assets272B12B2,267%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.95-17.3423%
Returns for 3 years4.35-13.13-33%
Returns for 5 years40.74-1.30-3,130%
Returns for 10 years38.82-20.50-189%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings